Siemens Healthcare has received 510(k) clearance from the FDA for the Biograph Horizon PET/CT system, which enables physicians to visualize small lesions early.

Health Diagnostics Laboratory, a bankrupt cardiac biomarker laboratory, filed a Chapter 11 liquidation plan, Richmond BizSense reports. In April, Health Diagnostics Laboratory agreed to pay $47 million to settle allegations from the Department of Justice that it paid doctors in exchange for patient referrals and billed Medicare for unnecessary testing.

Although doctors are relying more on echocardiograms and pocket-size ultrasound devices, cardiologists and other providers also continue to use stethoscopes, the Washington Post reports. In fact, the FDA last year approved a stethoscope that reproduces sounds on a cellphone app and sends them to an electronic medical record.

In 2016, consumers and clinicians will embrace technology to create a more connected healthcare system, according to a forward-looking report from the PwC Health Research Institute (HRI).

Cardiac Dimensions, a privately held medical device company, hired Gregory D. Casciaro as its CEO and President on Dec. 15.

A mobile stroke treatment unit (MSTU) equipped with telemedicine, including a neuroradiologist remotely assessing images obtained by mobile CT, may be an effective way to provide accurate care, according to a recent study published in JAMA Neurology that put Cleveland Clinic's unit to the test.

Eric Topol, MD, a cardiologist and director of the Scripps Translational Science Institute, wrote an editorial in the Wall Street Journal on the future of medicine. Topol predicts providers and patients will continuously monitor data and apply the findings to treat conditions such as heart failure.

Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval and U.S. commercial availability of the MyCareLink Smart(TM) Monitor, the world's first app-based remote monitoring system for patients with implantable pacemakers.